Status:
UNKNOWN
Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.
Lead Sponsor:
Sohag University
Conditions:
Premature Ejaculation
Eligibility:
MALE
20-50 years
Phase:
PHASE3
Brief Summary
Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of p...
Detailed Description
This study will be carried out on 60 patients with lifelong premature ejaculation and non-responding to dapoxetine alone. All patients will be equally divided into 2 groups (30 patients each). Group ...
Eligibility Criteria
Inclusion
- lifelong premature ejaculation and non-responding to dapoxetine alone.
Exclusion
- diabetes mellitus,
- chronic prostatitis,
- Advanced renal or hepatic diseases
- neurological diseases
- C.N.S. medications
Key Trial Info
Start Date :
March 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04703127
Start Date
March 30 2020
End Date
January 30 2021
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammed Abu El-Hamd
Sohag, Egypt, 82524